Letter to the Editor Regarding "Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C".
사설/논평
0/5 보강
APA
Gong T (2026). Letter to the Editor Regarding "Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C".. Journal of gastroenterology and hepatology, 41(2), 821-822. https://doi.org/10.1111/jgh.70229
MLA
Gong T. "Letter to the Editor Regarding "Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C".." Journal of gastroenterology and hepatology, vol. 41, no. 2, 2026, pp. 821-822.
PMID
41469490 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (4)
- Repurposing dronedarone for colorectal cancer therapeutic via suppression of the AKT/ERK signaling pathways.
- The effect of lidocaine in breast cancer: a concise overview of preclinical and clinical evidence.
- Neoadjuvant pamiparib plus abiraterone and androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: an open-label, single-arm, phase 2 study.
- Overcoming resistance in HER2-positive gastric cancer: a case report on the synergistic effect of pembrolizumab and trastuzumab.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Intra-procedural Cone-Beam Computed Tomography for Ultrasound-Guided Microwave Ablation of Hepatocellular Carcinoma: An Initial Experience.
- Matrix Metalloproteinases in Hepatocellular Carcinoma: Mechanistic Roles and Emerging Inhibitory Strategies for Therapeutic Intervention.
- DDX17-mediated raptor-dependent mTORC1 activation links autophagy inhibition and metabolic compensation in HCC development.
- Combinatorial treatment with donafenib and quercetin suppresses lipid metabolism in HepG2 cells by targeting the CREB1/DRP1/SREBP1 axis.
- Integrated Transcriptomic and Histological Analysis of TP53/CTNNB1 Mutations and Microvascular Invasion in Hepatocellular Carcinoma.
- Fine needle aspirates characterise the hepatocellular carcinoma immune niche to predict immune checkpoint inhibitor outcomes.